Dixon Hubard Feinour & Brown’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $360K | Sell |
3,783
-90
| -2% | -$8.57K | 0.04% | 222 |
|
|
2022
Q1 | $456K | Sell |
3,873
-100
| -3% | -$11.8K | 0.05% | 226 |
|
|
2021
Q4 | $515K | Buy |
3,973
+1,067
| +37% | +$138K | 0.05% | 208 |
|
|
2021
Q3 | $329K | Buy |
2,906
+15
| +0.5% | +$1.7K | 0.07% | 143 |
|
|
2021
Q2 | $299K | Sell |
2,891
-160
| -5% | -$16.5K | 0.06% | 155 |
|
|
2021
Q1 | $255K | Buy |
+3,051
| New | +$255K | 0.03% | 177 |
|
|
2020
Q3 | – | Sell |
-126,489
| Closed | -$9.8M | – | 183 |
|
|
2020
Q2 | $9.8M | Sell |
126,489
-6,192
| -5% | -$479K | 2.54% | 9 |
|
|
2020
Q1 | $8.34M | Sell |
132,681
-6,210
| -4% | -$390K | 2.82% | 7 |
|
|
2019
Q4 | $10.8M | Buy |
138,891
+570
| +0.4% | +$44.3K | 2.8% | 5 |
|
|
2019
Q3 | $10.1M | Buy |
138,321
+720
| +0.5% | +$52.8K | 2.81% | 7 |
|
|
2019
Q2 | $8.47M | Buy |
137,601
+660
| +0.5% | +$40.6K | 2.41% | 11 |
|
|
2019
Q1 | $8.73M | Sell |
136,941
-2,595
| -2% | -$166K | 2.63% | 8 |
|
|
2018
Q4 | $7.12M | Buy |
+139,536
| New | +$7.12M | 2.64% | 7 |
|
|
2016
Q4 | – | Sell |
-191,727
| Closed | -$7.71M | – | 176 |
|
|
2016
Q3 | $7.71M | Buy |
191,727
+900
| +0.5% | +$36.2K | 2.39% | 5 |
|
|
2016
Q2 | $6.34M | Hold |
190,827
| – | – | 2.03% | 15 |
|
|
2016
Q1 | $6.76M | Sell |
190,827
-4,395
| -2% | -$156K | 2.21% | 9 |
|
|
2015
Q4 | $5.14M | Buy |
+195,222
| New | +$5.14M | 1.64% | 21 |
|